Odyssey Health (ODYY) Research & Development (2021 - 2024)
Odyssey Health (ODYY) posted quarterly Research & Development of -$10600.0 for Q3 2024, down 133.83% year-over-year from $31329.0 in Q3 2023, and down 124.79% quarter-over-quarter from $42765.0 in Q1 2024.
Odyssey Health (ODYY) Research & Development (2021 - 2024) Analysis & Trends
Odyssey Health's Research & Development history runs 4 years deep, the most recent figure standing at -$10600.0 for Q3 2024.
- In Q3 2024, Research & Development fell 133.83% year-over-year to -$10600.0; the TTM figure through Apr 2025 stood at -$10600.0 (down 110.92% YoY), while the FY2024 annual figure was $55166.0, down 72.6% from the prior year.
- Research & Development for Q3 2024 stood at -$10600.0, down from $42765.0 in the prior quarter.
- The five-year high for Research & Development was $1.0 million in Q3 2021, with the low at -$10600.0 in Q3 2024.
- The 4-year median for Research & Development is $63139.0 (2022), against an average of $261093.5.
- Peak annual rise in Research & Development reached 999.64% in 2024, while the deepest fall reached 133.83% in 2024.
- Odyssey Health's Research & Development stood at $322504.0 in 2021, then gained by 9.83% to $354215.0 in 2022, then slumped by 93.51% to $23001.0 in 2023, then sank by 146.08% to -$10600.0 in 2024.
- Business Quant data shows ODYY's Research & Development at -$10600.0 in Q3 2024, $42765.0 in Q1 2024, and $23001.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2024 | -10,600.00 |
| Jan 31, 2024 | 42,765.00 |
| Oct 31, 2023 | 23,001.00 |
| Jul 31, 2023 | 31,329.00 |
| Jan 31, 2023 | 3,889.00 |
| Oct 31, 2022 | 354,215.00 |
| Jul 31, 2022 | 470,658.00 |
| Apr 30, 2022 | 63,139.00 |
| Jan 31, 2022 | 460,723.00 |
| Oct 31, 2021 | 322,504.00 |
| Jul 31, 2021 | 1.02 Mn |
| Apr 30, 2021 | 565,764.00 |
| Jan 31, 2021 | 42,619.00 |